SEC Filings - Supernus Pharmaceuticals

Filing date	Description	Form	Filing Group	View
April 12, 2023	Amendment to a previously filed 4	4/A	3,4,5	View HTML 0001104659-23-044665.pdf 0001104659-23-044665.xls
April 10, 2023	Statement of changes in beneficial ownership of securities	4	3,4,5	View HTML 0001104659-23-043635.pdf 0001104659-23-043635.xls
April 10, 2023	Statement of changes in beneficial ownership of securities	4	3,4,5	View HTML 0001104659-23-043634.pdf 0001104659-23-043634.xls
April 3, 2023	Report of unscheduled material events or corporate event	8-K	Current Reports	View HTML 0001356576-23-000020.pdf 0001356576-23-000020.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
March 16, 2023	Statement of changes in beneficial ownership of securities	4	3,4,5	View HTML 0001104659-23-033366.pdf 0001104659-23-033366.xls
March 9, 2023	Annual report which provides a comprehensive overview of the company for the past year	10-K	Annual Filings	View HTML 0001356576-23-000016.pdf 0001356576-23-000016.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
March 2, 2023	Notification that form 10-K will be submitted late	NT 10-K	Annual Filings	View HTML 0001356576-23-000013.pdf 0001356576-23-000013.xls
March 1, 2023	Report of unscheduled material events or corporate event	8-K	Current Reports	View HTML 0001104659-23-027420.pdf 0001104659-23-027420.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
February 28, 2023	Report of unscheduled material events or corporate event	8-K	Current Reports	View HTML 0001356576-23-000008.pdf 0001356576-23-000008.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
February 27, 2023	Statement of changes in beneficial ownership of securities	4	3,4,5	View HTML 0001104659-23-026081.pdf 0001104659-23-026081.xls

Data provided by Kaleidoscope.